ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,063Medicare Part D Prescriptions Filled, Including Refills

Rank: 157 out of 2604

$518K Total Retail Price of All Prescriptions

Rank: 190 out of 2604

446 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,331 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 429 356 1 2
LEVOTHYROXINE SODIUM 334 272 2 4
OMEPRAZOLE 296 238 3 5
HYDROCODONE-ACETAMINOPHEN 279 170 S3 4 1
FUROSEMIDE 276 250 5 8
LISINOPRIL 261 227 6 3
AMLODIPINE BESYLATE 206 186 7 6
GABAPENTIN 186 131 8 12
LOSARTAN POTASSIUM 151 119 9 20
METFORMIN HCL 142 112 10 7
ALENDRONATE SODIUM 140 110 11 29
JANTOVEN 118 111 12 118
POTASSIUM CHLORIDE 115 77 13 16
CARVEDILOL 106 100 14 26
ATENOLOL 104 93 15 11
FENOFIBRATE 102 73 16 69
METOPROLOL TARTRATE 96 90 17 9
TAMSULOSIN HCL 93 79 18 30
METOPROLOL SUCCINATE 90 77 19 17
PRAVASTATIN SODIUM 89 72 20 14
HYDROCHLOROTHIAZIDE 87 71 21 10
TRAMADOL HCL 87 81 21 15
ZETIA 86 78 23 94
ATORVASTATIN CALCIUM 86 65 23 19
WARFARIN SODIUM 84 63 25 13
MELOXICAM 77 71 26 36
RANITIDINE HCL 73 57 27 25
GLIMEPIRIDE 71 61 28 57
AZITHROMYCIN 70 61 29 33
DONEPEZIL HCL 67 55 30 28
KLOR-CON M20 67 67 30 86
ALLOPURINOL 64 53 32 35
CITALOPRAM HBR 64 53 32 18
FENTANYL 63 61 S2 34 48
CIPROFLOXACIN HCL 61 53 35 59
NAMENDA 61 61 35 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 49 35 22
PANTOPRAZOLE SODIUM 56 37 38 64
CLOPIDOGREL 54 46 39 39
ZOLPIDEM TARTRATE 53 41 40 21
ESCITALOPRAM OXALATE 53 45 40 73
PROAIR HFA 52 27 42 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.